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Oxidative stressThis study was undertaken to evaluate the effects of streptozotocin (STZ)-induced hyperglycemia and
insulin-induced hypoglycemia in cortical and hippocampal mitochondria bioenergetics and oxidative status.
For that purpose we used, citrate (vehicle)-treated Wistar rats, STZ-treated rats [i.p., 50 mg/kg body weight]
and STZ-treated rats injected with insulin [s.c., dose adjusted to blood glucose levels] 1 h prior to sacriﬁce to
induce an acute episode of hypoglycemia. Several parameters were analyzed: respiratory chain,
phosphorylation system, thiobarbituric acid reactive substances (TBARS) levels, hydrogen peroxide (H2O2)
production rate, and non-enzymatic and enzymatic antioxidant defenses. Cortical mitochondria from
insulin-induced hypoglycemic rats present a signiﬁcant decrease in the ADP/O index, a signiﬁcant increase in
the repolarization lag phase and a decrease in GSH/GSSG ratio when compared with STZ and control
mitochondria. Both STZ-induced diabetes and insulin-induced hypoglycemia promote a signiﬁcant increase
in TBARS levels and a decrease in glutathione disulﬁde reductase activity. Diabetic cortical mitochondria
present a signiﬁcant decrease in glutathione peroxidase (GPx) activity compared to control mitochondria. In
turn, insulin-induced hypoglycemia induced a signiﬁcant increase in GPx and manganese superoxide
dismutase (MnSOD) activities. In hippocampal mitochondria, insulin-induced hypoglycemia increases the
respiratory control ratio whereas both situations, hyper- and hypoglycemia, potentiate H2O2 production and
decrease the activity of MnSOD. These results suggest that the poor glycemic control that occurs in type 1
diabetic patients undergoing insulin therapy may have detrimental effects in brain areas involved in learning
and memory.and Cell Biology, Institute of
3000-354 Coimbra, Portugal.
com (P.I. Moreira).
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Diabetes mellitus is an endocrine disorder of carbohydrate
metabolism resulting from inadequate insulin release (type 1
diabetes) or insulin insensitivity (type 2 diabetes) [1]. Type 1 diabetes
represents a signiﬁcant health concern, given that it begins early in life
and leads to long-term complications including cardiovascular, renal
and central nervous system (CNS) complications [2]. Management of
type 1 diabetes requires special and continued insulin administration,
blood glucose monitoring and meal planning [2]. Nevertheless,
patients with type 1 diabetes experience daily ﬂuctuations in blood
glucose levels, ranging from low (hypoglycemia) to high (hypergly-
cemia) blood glucose levels [3].
In normal situations, glucose is the brain's main fuel and therefore
because the brain is dependent on a continuous delivery of glucose, it
cannot survive more than a few minutes of glucose deprivation [3].Insulin therapy brings the risk of hypoglycemic brain injury that is the
main obstacle occurring in insulin-dependent diabetic patients.
Hypoglycemia, depending on its severity, can cause irritability,
impaired concentration, neurological deﬁcits, seizures, coma and,
ultimately, neuronal death [4]. Hypoglycemic neuronal death is most
prominent in neurons from speciﬁc brain regions such as in the
hippocampus and superﬁcial layers of the cortex and striatum [5–7],
which may lead to deﬁcits in memory and learning [8]. A previous
epidemiological study reported that cognitive function in type 1
diabetic patients is generally well-maintained even at elevated blood
glucose levels but during hypoglycemia signiﬁcant decrements in
several areas of cognition occur, namely those involved in associative
learning skills [9]. Indeed, type 1 diabetic patients present impair-
ments in memory, learning and cognition [10]. Moreover, data show
that memory and learning processes are already affected after 20 days
of diabetes [11] and that after 10 weeks of STZ-induced diabetes,
diabetic rats present an impaired performance in the Morris water
maze test, which evaluate hippocampal-dependent learning [12].
Mitochondrial oxidative phosphorylation (OXPHOS) generates the
energy necessary to fuel cellular function whereas the dysfunction of
943S. Cardoso et al. / Biochimica et Biophysica Acta 1802 (2010) 942–951mitochondria leads to reduced ATP production, impaired calcium
buffering and the formation of reactive oxygen species (ROS) [13,14].
Mitochondria are both sources and targets of ROS actions. Situations
in which occurs a free radical overload will result in the damage of
proteins, DNA and membrane phospholipids. The impairment of
mitochondrial function together with increased oxidative stress has
been implicated in the pathogenesis of a wide range of diseases
including diabetes. Growing evidence show increased levels of lipid
peroxidation and a decrease in antioxidant defenses in brain
mitochondria from STZ-induced diabetic rats [15–17]. It was also
shown that mitochondrial permeability transition pore opening and
increased capacity to generate ROS are involved in the hypoglycemic-
induced cell death [18–20].
In light of those ﬁndings, and due to the scarcity of information
concerning mitochondrial bioenergetics and oxidative status in hyper-
and/or insulin-induced hypoglycemic conditions, this study was
undertaken to investigate how cortical and hippocampal mitochondria
are affected by STZ-induced diabetes, a model of type 1 diabetes, and
insulin-induced acute hypoglycemia. We evaluated respiratory para-
meters [states 3 and4 of respiration, respiratory control ratio (RCR), and
ADP/O index], phosphorylation system [transmembrane potential
(ΔΨm), repolarization level, repolarization lag phase], thiobarbituric
acid reactive substance (TBARS) levels, H2O2 production rate, non-
enzymatic (GSH/GSSG ratio) and enzymatic antioxidant [glutathione
peroxidase (GPx), glutathione disulﬁde reductase (GR) and manganese
superoxide dismutase (MnSOD)] defenses.
2. Materials and methods
2.1. Chemicals
STZ was obtained from Sigma (Portugal). Insulin (Actrapid Penﬁll)
was obtained from Novo Nordisk A/S (Denmark). All the other
chemicals were of the highest grade of purity commercially available.
2.2. Animals treatment
Male Wistar rats (3-month-old) were housed in our animal colony
(Laboratory Research Center, Faculty of Medicine, University of
Coimbra) and were maintained under controlled light (12-h day/
night cycle) and humidity with free access to water and powdered
rodent chow (except in the fasting period). Rats were deprived of food
overnight and were randomly divided in two groups. One group
received an i.p. injection of STZ (50 mg/kg body weight) freshly
dissolved in citrate 100 mM, pH 4.5. The volume administered was
always 0.5 ml/200 g animal body weight. The control group received
an i.p. injection with an equal volume of citrate (vehicle). In the
following 24 h, animals were orally fed with glycosylated serum in
order to avoid hypoglycemia resulting from the massive destruction of
β-cells and release of intracellular insulin associated with STZ
treatment [15]. Three days after STZ administration, the tail vein
blood glucose levels weremeasured in all animals and those presenting
levels above 250 mg/dl were considered diabetic. After 1 month of the
induction of diabetes, the STZ-diabetic rats were randomly divided in
two groups and one group received a s.c. injection of insulin (adjusted
to blood glucose levels; ≈30 U/N300 mg/dl) 1 h prior to sacriﬁce to
induce an acute episode of hypoglycemia. Animal handling and
sacriﬁce followed the procedures approved by the Federation of
European Laboratory Animal Science Associations (FELASA).
2.3. Determination of blood glucose and glycated hemoglobin levels
Blood glucose concentration was determined from the tail vein
using a commercial glucometer (Glucometer-Elite, Bayer, Portugal).
Hemoglobin A1C (HbA1c) levels were determined using Systems
SYNCHRON CX4 (Beckman). This utilizes two cartridges, Hb and A1cto determine A1c concentration as a percentage of total Hb. The
hemoglobin is measured by a colorimetric method and the A1c
concentration by a turbidimetric immunoinhibition method.
2.4. Preparation of mitochondrial fraction
Brieﬂy, after animal decapitation, hippocampus and cortex were
rapidly separated and homogenized in 10 ml of homogenization
medium (0.32 M sucrose, 10 mM HEPES, and 0.5 mM EGTA-K+, pH
7.4). The homogenate was centrifuged at 747×g (Sorvall Evolution RC
Ultra Centrifuge) for 10 min and the supernatant was again
centrifuged at 11952×g for 10 min. The pellet was resuspended in
10 ml of washing medium (0.32 M sucrose, 10 mM HEPES, pH 7.4)
and centrifuged at 11952×g for 10 min. The ﬁnal pellet was
resuspended in 200 μl of washing medium and mitochondrial protein
was determined by the biuret method calibrated with BSA [21].
2.5. Mitochondrial respiration measurements
Oxygen consumption of the brain mitochondria was registered
polarographically with a Clark oxygen electrode [22] connected to a
suitable recorder in a thermostated water-jacketed closed chamber
with magnetic stirring. The reactions were carried out at 30 °C in 1 ml
of standard respiratorymedium (100 mM sucrose, 100 mMKCl, 2 mM
KH2PO4, 5 mMHepes and 10 μMEGTA; pH 7.4) with 0.8 mg of protein.
Cortical and hippocampal mitochondria (0.8 mg/ml) were energized
with 5 mM succinate (substrate of complex II) in the presence of 2 μM
rotenone. State 3 of respiration was initiated with ADP (155 nmol/mg
protein). Respiratory control ratios (RCR=state 3/state 4), respira-
tory states, and ADP/O ratios were determined according to Chance
and Williams [23].
2.6. Mitochondrial membrane potential measurements
The transmembrane potential (ΔΨm) was monitored by evaluat-
ing transmembrane distribution of the lipophilic cation TPP+
(tetraphenylphosphonium) with a TPP+-selective electrode prepared
according to Kamo et al. [24] using an Ag/AgCl-saturated electrode
(Tacussel, model MI 402) as reference. TPP+ uptake has been
measured from the decreased TPP+ concentration in the medium
sensed by the electrode. The potential difference between the
selective electrode and the reference electrode was measured with
an electrometer and recorded continuously in a Linear 1200 recorder.
The voltage response of the TPP+ electrode to log[TPP+] was linear
with a slope of 59±1, in a good agreement with the Nernst equation.
Reactions were carried out in a chamber with magnetic stirring in
1 ml of the standard medium (100 mM sucrose, 100 mM KCl, 2 mM
KH2PO4, 5 mMHepes and 10 μMEGTA; pH 7.4) containing 3 μMTPP+.
This TPP+ concentration was chosen in order to achieve high
sensitivity in measurements and to avoid possible toxic effects on
mitochondria [25]. The ΔΨm was estimated by the equation: ΔΨm
(mV)=59 log(v/V)−59 log(10ΔE/59−1) as indicated by Kamo et al.
[24] and Muratsugu et al. [26]. v, V, and ΔE stand for mitochondrial
volume, volume of the incubation medium and deﬂection of the
electrode potential from the baseline, respectively. This equation was
derived assuming that TPP+ distribution between the mitochondria
and themedium follows the Nernst equation, and that the law ofmass
conservation is applicable. A matrix volume of 1.1 μl/mg protein was
assumed. No correction was made for the “passive” binding
contribution of TPP+ to the mitochondrial membranes, because the
purpose of the experimentswas to show relative changes in potentials
rather than absolute values. As a consequence, we can anticipate a
slight overestimation on ΔΨm values. However, the overestimation is
only signiﬁcant at ΔΨm values below 90 mV, therefore, far from our
measurements. Cortical and hippocampal mitochondria (0.8 mg/ml)
were energizedwith 5 mM succinate in the presence of 2 μMrotenone
Table 1
Characterization of the experimental animal models.
Control STZ Insulin-induced hypoglycemia
Body weight (g) 354±4 259±11⁎⁎⁎ 245±9⁎⁎⁎
Brain weight (g) 2.5±0.2 2.4±0.1 2.4±0.2
Glucose (mg/dl) 89±3 415±26*** 33±3***;+++
HbA1C (%) 1.9±0.2 7.8±0.4⁎⁎ 7.0±0.2⁎⁎
Data are the means±SEM of 12–14 animals from each condition studied. Statistical
signiﬁcance: ***pb0.001;**pb0.01 when compared with Control rats; +++pb0.001
when compared with STZ-treated rats. HbA1C—glycated hemoglobin.
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steady-state distribution of TPP+ had been reached (ca. 1 min of
recording), ΔΨm ﬂuctuations were recorded.
2.7. Measurement of thiobarbituric acid reactive substances (TBARS) levels
TBARS levels were determined by using the thiobarbituric acid
assay (TBA), according to a modiﬁed procedure described by Ernster
and Nordenbrand [27]. The amount of TBARS formed was calculated
using a molar coefﬁcient of 1.56×105 M−1 cm−1 and expressed as
nmol TBARS/mg protein.
2.8. Measurement of hydrogen peroxide (H2O2) production rate
H2O2 levels weremeasured ﬂuorimetrically using amodiﬁcation of
the method described by Barja [28]. Brieﬂy, cortical and hippocampal
mitochondria (0.2 mg) were incubated at 37 °C with 10 mM succinate
in 1.5 ml of phosphate buffer, pH 7.4, containing 0.1 mM EGTA, 5 mMFig. 1. Effect of STZ-induced diabetes and insulin-induced hypoglycemia in the cortical mitoch
index (D). Data are the mean±SEM of 8–10 animals from each condition studied. Statistic
when compared with STZ cortical mitochondria.KH2PO4, 3 mM MgCl2, 145 mM KCl, 30 mM Hepes, 0.1 mM homo-
valinic acid and 6 U/ml horseradish peroxidase. After 15 min, the
reaction was stopped with 0.5 ml cold stop solution (0.1 M glycine,
25 mM EDTA-NaOH, pH 12). Fluorescence was determined at 312 nm
excitation and 420 nm emission wavelengths. The H2O2 levels were
calculated using a standard curve of H2O2 and expressed as pmol/mg
protein/15 min.
2.9. Measurement of glutathione (GSH) and glutathione disulﬁde (GSSG)
levels
GSH andGSSG levels were determinedwith ﬂuorescence detection
after reaction of the supernatant containing H3PO4/NaH2PO4-EDTA or
H3PO4/NaOH, respectively, of the deproteinized homogenates solu-
tion with ophthalaldehyde (OPT), pH 8.0, according to Hissin and Hilf
[29]. In brief, freshly isolated cortical and hippocampal mitochondria
(1 mg) resuspended in 1.5 ml phosphate buffer (100 mM NaH2PO4,
5 mM EDTA, pH 8.0) and 500 μl H3PO4 4.5% were rapidly centrifuged
at 50,000 rpm (Beckman, TL-100 Ultracentrifuge) for 30 min. For GSH
determination, 100 μl of supernatant was added to 1.8 ml phosphate
buffer and 100 μl OPT. After thorough mixing and incubation at room
temperature for 15 min, the solution was transferred to a quartz
cuvette and the ﬂuorescence was measured at 420 and 350 nm
emission and excitation wavelength, respectively. For GSSG determi-
nation, 250 μl of the supernatant was added to 100 μl of N-
ethylmaleymide and incubated at room temperature for 30 min.
After the incubation 140 μl of the mixture was added to 1.76 ml NaOH
(100 mM) buffer and 100 μl OPT. After mixing and incubation at room
temperature for 15 min, the solution was transferred to a quartzondria respiratory parameters: states 3 (A) and 4 (B) of respiration, RCR (C) and ADP/O
al signiﬁcance: **pb0.01 when compared with control cortical mitochondria; +pb0.05
Table 2
Effect of STZ-induced diabetes and insulin-induced hypoglycemia in the cortical
mitochondrial oxidative phosphorylation system (ΔΨm, repolarization level and
repolarization lag phase).
Control STZ Insulin-induced
hypoglycemia
ΔΨm (−mV) 179±2 182±2 179±3
Repolarization level (−mV) 144±2 146±2 145±2
Repolarization lag phase (min) 2.1±0.1 2.1±0.1 2.9±0.2**;+
The oxidative phosphorylation parameters were evaluated in freshly isolated cortical
mitochondrial fractions (0.8 mg) in 1 ml of the reaction medium supplemented with
3 μM of TPP+ and energized with 5 mM succinate in the presence of 2 μM rotenone.
Data are the mean±SEM of 8–10 animals from each condition studied. Statistical
signiﬁcance: **pb0.01 when compared with control cortical mitochondria; +pb0.05
when compared with STZ cortical mitochondria.
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emission and excitation wavelength, respectively. The GSH and GSSG
levels were determined from comparisons with a linear GSH or GSSG
standard curve, respectively.
2.10. Measurement of glutathione peroxidase (GPx) activity
GPx activity was determined spectrophotometrically at 340 nm by
following the method of Flohé and Günzler [30]. Brieﬂy, the activity of
GPx was measured upon a 5 min incubation, in the dark, of 0.1 mg of
each sample with 0.5 mM phosphate buffer (0.25 M KH2PO4, 0.25 M
K2HPO4 and 0.5 mM EDTA, pH 7.0), 0.5 mM EDTA, 1 mM GSH and 2.4
U/ml glutathione reductase. The quantiﬁcation occurred after the
addition of 0.2 mM NADPH and 1.2 mM tert-butyl hydroperoxide, at
30 °C with continuous magnetic stirring, for 5 min, in a Jasco V560
UV/VIS Spectrophotometer. The measurements were made against
blanks prepared in the absence of NADPH. GPx activity was
determined using the molar extinction coefﬁcient 6220 M−1 cm−1
and expressed as nmol/min/mg protein.Fig. 2. Representative traces of oxygen uptake in cortical mitochondria from each condition
medium were energized with 5 mM succinate in the presence of 2 μM rotenone. State 3 of2.11. Measurement of glutathione disulﬁde reductase (GR) activity
For the activity of GR, 0.1 mg of each sample was incubated for
1 min with 0.2 mM phosphate buffer (containing 0.2 M K2HPO4 and
2 mM EDTA, pH 7.0) and 2 mM NADPH. The measurements were
made at 340 nm and initiated with the addition of 20 mM GSSG, at
30 °C, with continuous magnetic stirring, for 4 min, against blanks
prepared in the absence of GSSG, using a Jasco V560 UV/VIS
Spectrophotometer [31]. GR activity was determined using the
molar extinction coefﬁcient 6220 M−1 cm−1 and expressed as
nmol/min/mg protein.2.12. Measurement of manganese superoxide dismutase (MnSOD) activity
MnSOD activity was determined spectrophotometrically, at 550 nm
[32]. After the incubation of 0.1 mg of protein with 0.07 mM of
phosphate buffer (50 mM K2HPO4 and 100 μM EDTA, pH 7.8),
0.025 mMhypoxanthine, 0.025 Triton X-100, 0.1 mMnitrobluetetrazo-
lium (NBT) and 1.33 mM KCN, the reaction was started with the
addition of 0.025 U/ml xanthine oxidase, and the reaction was allowed
to continue for 3 min at 25 °C, with continuous magnetic stirring. The
measurements were performed in a Jasco V560 UV/VIS Spectropho-
tometer, against a blank, prepared in the absence of hypoxanthine. The
activity ofMnSODwas calculated using a standard curve, preparedwith
different concentrations of superoxide dismutase.2.13. Statistical analysis
Data were analyzed using SPSS 16.0 for Windows. Results are
presented as mean±SEM of the indicated number of experiments.
Statistical signiﬁcance between groups was deﬁned using the Mann–
Whitney U-test. A p-valueb0.05 was considered signiﬁcant.studied. Freshly isolated cortical brain mitochondria (0.8 mg) in 1 ml of the reaction
respiration was initiated with ADP (155 nmol/mg protein).
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3.1. Characterization of the experimental animals
STZ rats present signiﬁcantly higher values of glycemia and
glycated hemoglobin (HbA1C) and a signiﬁcant decrease in body
weight when compared with control rats (Table 1), conﬁrming the
diabetic state of STZ animals. As expected, insulin-induced hypogly-
cemia decreased signiﬁcantly blood glucose levels when compared
with STZ and control rats and the glycated hemoglobin values are
similar to those of STZ rats (Table 1).
3.2. Effects of diabetes and insulin-induced hypoglycemia in the
respiratory chain and phosphorylation system of cortical and
hippocampal mitochondria
ΔΨm is fundamental for the phenomenon of OXPHOS, which results
in the conversion of ADP to ATP via ATP synthase. Mitochondrial
respiratory chain pumps H+ out of the mitochondrial matrix across the
inner mitochondrial membrane. The H+ gradient originates an
electrochemical potential (Δp) resulting in a pH (ΔpH) and a voltage
gradient (ΔΨm) across the inner membrane. Insulin-induced hypogly-
cemia promoted a signiﬁcant decrease in ADP/O index (a marker of the
mitochondrial ability to couple oxygen consumption to ADP phosphor-
ylation during state 3 of respiration) (Fig. 1) and an increase in
repolarization lag phase (time necessary for ADP phosphorylation)
(Table 2) in cortical mitochondria when compared with STZ-induced
diabetic and control rats. No statistical differences were observed in the
other parameters evaluated in cortical mitochondria (Figs. 1 and 2 and
Table 2). In hippocampal mitochondria insulin-induced hypoglycemiaFig. 3. Effect of STZ-induced diabetes and insulin-induced hypoglycemia in the hippocampal
ADP/O index (D). Data are the mean±SEM of 6–10 animals from each condition studied. Sta
+pb0.05 when compared with STZ hippocampal mitochondria.signiﬁcantly increased RCR (ratio between states 3 and 4 of respiration)
when compared with control and STZ rats (Fig. 3). However, no
statistical differences were found in the phosphorylation system
parameters: ΔΨm, repolarization level (capacity of the mitochondria to
recover ΔΨm after ADP phosphorylation) and repolarization lag phase
(Table 3).
3.3. Effects of diabetes and insulin-induced hypoglycemia in the
susceptibility of cortical and hippocampal mitochondria to oxidative
stress and damage
Lipid peroxidation is a marker of oxidative damage. Fig. 4A and B
shows that cortical and hippocampal mitochondria from the three
groups of rats do not have signiﬁcant alterations in TBARS levels in the
absence of the pro-oxidant pair ADP/Fe2+ (basal conditions). In the
presence of ADP/Fe2+ (Px), cortical mitochondria of STZ and insulin-
induced hypoglycemic rats present a signiﬁcant increase in TBARS
levels when compared with control cortical mitochondria (Fig. 4A).
However, no signiﬁcant alterations were observed in hippocampal
mitochondria in the presence of ADP/Fe2+ (Px) (Fig. 4B).
The production of H2O2 by mitochondria gives an indication of the
pro-oxidant state of mitochondria. Fig. 5B shows that hippocampal
mitochondria from STZ and insulin-induced hypoglycemic rats present
a signiﬁcant increase in H2O2 production when compared with control
mitochondria. Additionally, hippocampal mitochondria from insulin-
induced hypoglycemic animals produce signiﬁcantly higher levels of
H2O2 when compared with STZ hippocampal mitochondria (Fig. 5B).
However, H2O2 production remained statistical unchanged in cortical
mitochondria isolated from the three groups of experimental animals
(Fig. 5A).mitochondria respiratory parameters: states 3 (A) and 4 (B) of respiration, RCR (C) and
tistical signiﬁcance: *pb0.05 when compared with control hippocampal mitochondria;
Table 3
Effect of STZ-induced diabetes and insulin-induced hypoglycemia in the hippocampal
mitochondrial oxidative phosphorylation system (ΔΨm, repolarization level and
repolarization lag phase).
Control STZ Insulin-induced
hypoglycemia
ΔΨm (−mV) 173±3 178±3 178±3
Repolarization level (−mV) 145±5 137±5 152±2
Repolarization lag phase (min) 2.7±0.4 3.1±0.4 1.92±0.3
Theoxidative phosphorylation parameterswere evaluated in freshly isolatedhippocampal
mitochondrial fractions (0.8 mg) in 1 ml of the reactionmedium supplementedwith 3 μM
of TPP+ and energizedwith 5 mMsuccinate in the presence of 2 μMrotenone. Data are the
mean±SEM of 6–10 animals from each condition studied.
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antioxidant defenses of cortical and hippocampal mitochondria
Mitochondria possess a multi-leveled ROS defense network that
includes non-enzymatic antioxidants like GSH and antioxidant
enzymes such as GPx, GR and MnSOD. Fig. 6A shows that insulin-
induced hypoglycemic cortical mitochondria present a signiﬁcant
decrease in GSH/GSSG ratio when compared to diabetic and control
situations. In hippocampal mitochondria no statistical changes in the
GSH/GSSG ratio were detected (Fig. 6B).Fig. 4. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on thiobarbituric
acid reactive substances (TBARS) formation induced by the pro-oxidant pair ADP/Fe2+
(Px) in cortical (A) and hippocampal (B) mitochondria. Freshly isolated mitochondria
were incubated at 1 mg/ml under standard conditions as described in the Materials and
methods section. Data shown representmean±SEM from 6–8 independent experiments.
Statistical signiﬁcance: ***pb0.001;*pb0.05 when compared with control cortical
mitochondria in the presence of ADP/Fe2+ (Px).
Fig. 5. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on hydrogen
peroxide (H2O2) production. Cortical (A) and hippocampal (B) mitochondria were
incubated under the conditions described in the Materials and methods section. Data
are the mean±SEM from 6–10 independent experiments. Statistical signiﬁcance:
*pb0.05 when compared with control hippocampal mitochondria; +pb0.05 when
compared with STZ hippocampal mitochondria.GPx activity is signiﬁcantly decreased in cortical mitochondria
isolated from STZ diabetic rats when compared with control
mitochondria (Fig. 7A). However, insulin-induced hypoglycemia
increased the activity of this enzyme when compared with diabetic
mitochondria (Fig. 7A). No differences were observed in hippocampal
mitochondria from all experimental groups, although it is visible a
slight decrease in the activity of this enzyme in diabetic and insulin-
induced hypoglycemic situations (Fig. 7B). STZ-induced diabetes and
insulin-induced hypoglycemia signiﬁcantly decreased GR activity in
cortical mitochondria (Fig. 8A) but had no signiﬁcant effects in
hippocampal mitochondria (Fig. 8B). MnSOD activity increased
signiﬁcantly in insulin-induced hypoglycemic cortical mitochondria
(Fig. 9A) but decreased signiﬁcantly in hippocampal mitochondria
from STZ and insulin-induced hypoglycemic rats when compared
with control animals (Fig. 9B). No signiﬁcant alterations were
observed in the citrate synthase activity of mitochondria isolated
from the different groups of experimental animals (data not shown).
4. Discussion
This study shows that STZ-induced diabetes and/or insulin-
induced hypoglycemia affects differently hippocampal and cortical
mitochondria bioenergetics and oxidative status suggesting that these
brain areas have speciﬁc differences in mitochondrial function and
Fig. 6. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on glutathione
content in cortical (A) and hippocampal (B)mitochondria. Data shown representmean±
SEM from 6–8 independent experiments. Statistical signiﬁcance: **pb0.01 when
compared with control brain mitochondria. +pb0.05 when compared with STZ cortical
mitochondria.
Fig. 7. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on glutathione
peroxidase (GPx) activity in cortical (A) and hippocampal (B) mitochondria. Data are
the mean±SEM of 6–8 animals from each condition studied. Statistical signiﬁcance:
**pb0.01 when compared with control cortical mitochondria; +pb0.05 when
compared with STZ cortical mitochondria.
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susceptibilities of distinct brain areas to metabolic insults.
Characterization of STZ animals was made by measuring blood
glucose and HbA1c levels and body weight. Diabetic rats presented a
signiﬁcant increase in glucose and HbA1c levels and a signiﬁcant
decrease in body weight when compared with control rats (Table 1).
This is in agreement with biochemical characteristics of type 1
diabetic patients [33]. Insulin therapy despite being used to
ameliorate diabetes-induced complications is also associated with
hypoglycemic episodes [34]. In in vivo studies intended to evaluate
hypoglycemia effects, it is necessary to adequate the insulin dosage to
the purpose of the study. When the goal of the work is to evaluate an
acute episode of hypoglycemia, insulin dosage used often leads to
blood glucose levels of about 30–50 mg/dl [35,36]. Accordingly, we
adjusted the levels of insulin administered to diabetic animals in order
to achieve blood glucose levels around 33 mg/dl (Table 1).
Brain requires a continuous glucose delivery [37] and, conse-
quently, episodes of hypoglycemia and chronically elevated or
ﬂuctuating glucose levels, may compromise brain structure or the
proper functioning of speciﬁc pathways or regions in the brain leading
to cognitive decline [3]. Neuronal processes are critically dependent
on mitochondrial function. This is reﬂected by the high oxygen
demand of CNS that consumes 20% of all inspired oxygen although it
accounts only for 2% of total body weight [38]. In addition, OXPHOS
provides 90% of the ATP required for the normal functioning of
neurons [14]. Previous data from our laboratory show that 4 weeks of
STZ-induced diabetes do not affect the OXPHOS capacity neither the
respiratory chain of total brain mitochondria [39]. Accordingly, thepresent study shows that cortical mitochondria isolated from STZ
diabetic rats do not show differences in the OXPHOS (Table 2) or in
the respiratory chain parameters (Figs. 1 and 2).
Insulin is an important neuromodulator, being involved in several
neurobiological processes such as energy homeostasis and cognition
[40]. It has been previously shown that insulin exerts neuroprotection
against oxidative stress and modulates synaptosomal γ-aminobutyric
acid and glutamate transport under oxidizing and/or diabetic condi-
tions [41,42]. A previous study from our laboratory showed that total
brainmitochondria from STZ-diabetic rats treatedwith insulin aremore
resistant to the deleterious effects promoted by the amyloidogenic
peptide Aβ1–40 [15]. Although insulin does not affect basal mitochon-
dria function, it prevents the decline in OXPHOS efﬁciency and avoids
the increase in oxidative stress promoted byAβ1–40 [15]. In the present
study we used insulin to induce an acute episode of hypoglycemia.
Under those conditions a signiﬁcant decrease in ADP/O index (Figs. 1
and 2) and an increase in lag phase (Table 2) were observed indicating
that insulin-induced hypoglycemic cortical mitochondria consume
more oxygen and spend more time to phosphorylate the amount of
ADP present in the medium. It has been previously demonstrated that
when hypoglycemia is prolonged from 30 to 60 min, the number of
irreversible damaged cells increases substantially [43]. Furthermore, a
signiﬁcant decrease in ADP/O index was observed in brain mitochon-
dria exposed to 60 min of severe hypoglycemia [44].
TheOXPHOS system is amajor sourceof free radicals includingH2O2,
hydroxyl (HO•), and superoxide anion (O2•−). ROS, besides being
important signaling molecules involved in synaptic transmission and
acting as second messengers in several signaling pathways, are key
Fig. 8. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on glutathione
disulﬁde reductase (GR) activity in cortical (A) and hippocampal (B) mitochondria.
Data are the mean±SEM of 6–8 animals from each condition studied. Statistical
signiﬁcance: **pb0.01 when compared with control cortical mitochondria.
Fig. 9. Effect of STZ-induced diabetes and insulin-induced hypoglycemia on superoxide
dismutase (MnSOD) activity in cortical (A) and hippocampal mitochondria (B). Data are
the mean±SEM of 6–8 animals from each condition studied. Statistical signiﬁcance:
*pb0.05 when compared with control; +pb0.05 when compared with STZ hippocampal
mitochondria.
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suggested to be involved in the aging process and in the pathogenesis of
neurodegenerative disorders and diabetes [13,45]. Excessive ROS
production, which could be caused by hyperglycemia [46] and/or
hypoglycemia [47], is associated with decreased activity of antioxidant
systems [48]. The antioxidant defense system is comprised by
antioxidant enzymes that catalyses the cellulardetoxiﬁcation of reactive
species. MnSOD is an intracellular enzyme that dismutates O2•− into
H2O2, which can be converted to H2O through the action of catalase or
GPx in thepresence ofGSH.GRensures the replenishmentofGSH, oneof
the most important cellular antioxidant. Indeed, data show that
hypoglycemia and diabetes lead to a decrease in glutathione content
and MnSOD and catalase activities and to an increase in lipid
peroxidation in several brain areas [49]. Accordingly, we observed
that cortical mitochondria isolated from insulin-induced hypoglycemic
and STZ-induced diabetic rats present a signiﬁcant increase in TBARS
levels in the presence of the pro-oxidant pair ADP/Fe2+ (Fig. 4A). This
increase in lipid peroxidation could be an indicator of the degree of
oxidative stress during insulin-induced hypoglycemia and/or STZ-
induced diabetes [49]. In STZ-induced diabetes we found a signiﬁcant
decrease in GPx (Fig. 7A) and GR (Fig. 8A) activities when compared
with control mitochondria. These decreases correlate with the GSH/
GSSG ratio, which remained statistically unchanged (Fig. 6A). Also,
Baydas et al. [50] reported an increase in lipid peroxidation levels in
hippocampus, cortex and cerebellumof STZ-induced diabetic rats while
the GSH levels suffer no signiﬁcant alterations. Previous data from our
laboratory show that the maintenance of GSH content in total brain
mitochondria isolated from STZ rats could be correlated with the
preservation of ΔΨm [15], since ΔΨm contributes for keeping matrixNADPH/NADP+ pool in the reduced form, which in turn helps to
maintain the matrix glutathione in the reduced state [14]. Similarly, we
found no differences in the OXPHOS of cortical mitochondria from STZ
diabetic rats (Table 2). Moreover, although cortical mitochondria from
STZ diabetic rats are more prone to lipid peroxidation, the high levels of
GSH help to maintain H2O2 production levels unchanged (Fig. 5A)
maybe in an attempt to keep normal mitochondrial function.
GSH/GSSG ratio decreased signiﬁcantly in the insulin-induced
hypoglycemic cortical mitochondria compared with STZ and control
mitochondria (Fig. 6A). GSH is an antioxidant that protects mitochon-
dria from lipid peroxidation and when depleted causes brain mito-
chondria enlargement and degeneration [51]. In agreement, we also
found a signiﬁcant decrease in GR activity compared with control rats
(Fig. 8A) and an increase in GPx activity compared with STZ-induced
diabetic animals (Fig. 7A). The increase in GPx activity (Fig. 7A) may
indicate an adaptive mechanism developed during the insulin-induced
hypoglycemic insult to counteract the overproduction of H2O2 promot-
ed by the increased activity of MnSOD (Fig. 9A). Accordingly, H2O2
production levels remained statistically unchanged (Fig. 5A). Therefore,
during the insulin-induced hypoglycemic insult, due to the attempt to
counterbalance the increased production of H2O2, the GSH pool was
depleted and, since the cells are unable to replace the GHS pool they
become more vulnerable to the metabolic insult.
In hippocampal mitochondria we observed a signiﬁcant decrease in
MnSOD activity (Fig. 9B) under hyperglycemic and insulin-induced
hypoglycemic situations. This may cause an accumulation of O2•−
potentiating the formation of other radicals disturbing the cellular
redox status. The role of MnSOD is critical in protecting neurons from
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with the activity of H2O2 detoxifying enzymes. Matrix GSH redox cycle
in coordination with MnSOD mediated scavenging of O2•− is crucial for
preventing excessive H2O2 accumulation [52]. However, the hyper- and
insulin-induced hypoglycemic conditions also lead to a signiﬁcant
increase in H2O2 production levels (Fig. 5B) and a non-statistically
signiﬁcant decrease in GPx activity (Fig. 7B). Similar results were
obtained by Aragno et al. [53] that reported an increase in H2O2 levels
and a decrease in GPx and catalase activities in the hippocampus of STZ-
diabetic rats. H2O2 in the presence of reduced transition metals, such as
Fe2+, can be converted to toxic HO• through Fenton and/orHaberWeiss
reactions [14]. The lack of correlation between MnSOD (Fig. 9B), GPx
(Fig. 7B) and H2O2 production levels (Fig. 5B) may suggest that H2O2
production in hippocampus does not result (only) from the dismutation
ofmitochondrialO2•−. Sinceourpreparationconsisted inamitochondrial
crude preparation the H2O2 can also be originated from an extra-
mitochondrial source [54]. Hino et al. [55] evaluated the effects of
insulin-induced hypoglycemia in hippocampal cells and glucose-
deprived medium in cultured neurons and they found a signiﬁcant
increase in GSSG levels in both experimental situations. However, we
found no differences in the GSH/GSSG ratio in hippocampal mitochon-
dria (Fig. 6B) that could be correlated with TBARS levels (Fig. 4A). We
should take into account our experiments were performed in
mitochondrial crude preparations while the above-mentioned studies
were performed in cells. Also, although not statistically signiﬁcant, we
observed a slight increase of GR activity (Fig. 8B). Therefore, and
compared to cortical mitochondria, both hyperglycemia and insulin-
induced hypoglycemia promote distinct effects in the oxidative status of
hippocampal mitochondria: a decrease in MnSOD activity and an
increase in H2O2 levels associated with the maintenance of the GSH/
GSSG ratio and GPx and GR activities.
The literature shows that glucose deprivation in hippocampal
neurons and cultured cerebellar granule neurons exacerbates the
production of ROS, which is accompanied by an increase in Ca2+
concentration and decrease in ΔΨm [56,57]. In this study we found no
differences in the OXPHOS (Table 3) but, interestingly, we found a
signiﬁcant increase in RCR in insulin-induced hypoglycemic hippocam-
pal mitochondria (Fig. 3). The rate of H2O2 production usually depends
on theΔΨm that, in turn, depends on the coupling andmetabolic state of
mitochondria [58]. Furthermore, evidence show that themaximum rate
of H2O2 production in heart mitochondria requires a high ΔΨm and
respiring, coupled mitochondria [59]. Moreover, Starkov et al. [60]
proposed that the rates ofH2O2 production in the rat brainmitochondria
could not bedirectly related to relative rates of state 3 or 4 of respiration.
It has been described that different brain regions have distinct
vulnerabilities to oxidative stress and that the cortex possess lower
basal level of antioxidant enzymes and therefore, is more prone to
oxidative damage [61]. A previous study showed that cortical areas
and hippocampus of 20-week-old Wistar rats possess different levels
of cooper (Cu), iron (Fe) and zinc (Zn), trace elements known to be
involved in neurological degenerative disorders, which are higher in
cortex compared to the hippocampus [62]. In fact, studies show that
hyperglycemia differently affects cortical and hippocampal morphol-
ogy and biochemistry [63]. Additionally, Xu et al. [64] demonstrated
that cortical neurons and astrocytes are more vulnerable to oxygen-
glucose deprivation than cells from striatum and hippocampus. Bree
et al. [65] demonstrated that diabetes uniquely increases the cortex
susceptibility to hypoglycemic damage. The differences in cortical and
hippocampal mitochondrial bioenergetics and antioxidant defenses
observed in the present study may explain the different suscept-
ibilities found in different brain areas.
5. Conclusions
The cerebral cortex and the hippocampus are the seat of our
highest forms of intelligence. Although both situations of hypergly-cemia and insulin-induced hypoglycemia lead to an increase in ROS
levels associated with a decrease in antioxidant defenses in cortical
and hippocampal mitochondria, we observed that both brain areas
behave differently in response to a metabolic insult. Furthermore, we
show that an acute episode of hypoglycemia induced by insulin
potentiates the effects of STZ-induced diabetes having detrimental
effects in cortical mitochondria bioenergetics and making the
antioxidant defenses unable of overcome the increased oxidative
stress. Therefore, the poor glycemic control that occurs in diabetic
patients undergoing insulin therapy may have a negative impact in
brain mitochondria, namely those of the cortex, predisposing the
brain to degenerative events and cognitive impairment.
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